Literature DB >> 24253249

Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study.

Stéphane Blanche1, Daniel Scott-Algara, Jérôme Le Chenadec, Céline Didier, Thomas Montange, Véronique Avettand-Fenoel, Christine Rouzioux, Adeline Mélard, Jean-Paul Viard, Catherine Dollfus, Naima Bouallag, Josiane Warszawski, Florence Buseyne.   

Abstract

BACKGROUND: Children born at the start of the human immunodeficiency virus (HIV) epidemic and infected during the perinatal period are now young adults living with the virus. Naive T-lymphocyte restoration is essential for the maintenance of a diverse T-cell receptor repertoire and for immunity to pathogens.
METHODS: The ANRS-EP38-IMMIP study included 93 patients infected with HIV type 1 (HIV-1) during the perinatal period. Naive CD4 (CD4N) and CD8 (CD8N) T lymphocytes and CD4 recent thymic emigrants (CD4RTE) were quantified in the peripheral blood by flow cytometry. Wilcoxon tests, Pearson correlation coefficients, and linear regressions were used to study their associations with HIV disease parameters.
RESULTS: Median CD4N, CD8N, and CD4RTE percentages were 56% (interquartile range [IQR], 44-64), 31% (IQR, 22-44), and 79% (IQR, 74-83), respectively. The three T-lymphocyte subsets were positively correlated with CD4 T-cell count. Patients aviremic at the time of the study tended to have a lower CD4N percentage (55% vs 58%; P = .10), a significantly higher CD8N percentage (39% vs 22%; P < .0001), and a significantly lower CD4RTE percentage (77% vs 81%; P = .003) than viremic patients. In aviremic patients, CD4N percentages were positively associated with cumulative viremia over the last 10 years (r = 0.335; P = .01) and were significantly higher in patients harboring X4R5 viruses than in those harboring R5 viruses (61% vs 44%; P = .001).
CONCLUSIONS: After at least 15 years of HIV infection, perinatally infected youths had preserved CD4N and CD4RTE levels. This persistence of high levels of thymic activity potentially compensating for the deleterious effects of current and past HIV replication is remarkable.

Entities:  

Keywords:  CD4 T-cell count; cumulative viremia; naive T lymphocyte; perinatal HIV infection; thymus

Mesh:

Year:  2013        PMID: 24253249     DOI: 10.1093/cid/cit729

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Thymic Function Failure Is Associated With Human Immunodeficiency Virus Disease Progression.

Authors:  Sara Ferrando-Martinez; Rebeca S De Pablo-Bernal; Marta De Luna-Romero; Santiago J De Ory; Miguel Genebat; Yolanda M Pacheco; Francisco J Parras; Marta Montero; Jose Ramón Blanco; Felix Gutierrez; Jesus Santos; Francisco Vidal; Richard A Koup; María Ángeles Muñoz-Fernández; Manuel Leal; Ezequiel Ruiz-Mateos
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

2.  Recent Thymus Emigrant CD4+ T Cells Predict HIV Disease Progression in Patients With Perinatally Acquired HIV.

Authors:  Ramia Zakhour; Dat Q Tran; Guenet Degaffe; Cynthia S Bell; Elizabeth Donnachie; Weihe Zhang; Norma Pérez; Laura J Benjamins; Gabriela Del Bianco; Gilhen Rodriguez; James R Murphy; Gloria P Heresi
Journal:  Clin Infect Dis       Date:  2016-02-21       Impact factor: 9.079

3.  CD31 Expression on CD4+ Cells: A Simple Method for Quantitation of Recent Thymus Emigrant CD4 Cells.

Authors:  Ramia Zakhour; Dat Q Tran; Gloria P Heresi; Guenet Degaffe; Cynthia S Bell; Elizabeth Donnachie; Weihe Zhang; Norma Pérez; Laura J Benjamins; Gabriela Del Bianco; Gilhen Rodriguez; James R Murphy
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

4.  Cervical HPV infection in Romanian women infected with HIV during early childhood.

Authors:  Luminita Ene; Cristina Voinea; Claudia Stefanescu; Diana Sima; Dan Duiculescu; Sanjay R Mehta
Journal:  Int J STD AIDS       Date:  2015-09-24       Impact factor: 1.359

Review 5.  Assessing immune aging in HIV-infected patients.

Authors:  Victor Appay; Delphine Sauce
Journal:  Virulence       Date:  2016-06-16       Impact factor: 5.882

6.  Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents - The-ANRS-EP59-CLEAC Study.

Authors:  Pierre Frange; Thomas Montange; Jérôme Le Chenadec; Damien Batalie; Ingrid Fert; Catherine Dollfus; Albert Faye; Stéphane Blanche; Anne Chacé; Corine Fourcade; Isabelle Hau; Martine Levine; Nizar Mahlaoui; Valérie Marcou; Marie-Dominique Tabone; Florence Veber; Alexandre Hoctin; Thierry Wack; Véronique Avettand-Fenoël; Josiane Warszawski; Florence Buseyne
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

7.  Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study.

Authors:  Jérôme Le Chenadec; Daniel Scott-Algara; Stéphane Blanche; Céline Didier; Thomas Montange; Jean-Paul Viard; Catherine Dollfus; Véronique Avettand-Fenoel; Christine Rouzioux; Josiane Warszawski; Florence Buseyne
Journal:  PLoS One       Date:  2015-12-09       Impact factor: 3.240

8.  Gag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP Study.

Authors:  Josiane Warszawski; Véronique Avettand-Fenoel; Christine Rouzioux; Daniel Scott-Algara; Thomas Montange; Céline Didier; Jérôme Le Chenadec; Jean-Paul Viard; Catherine Dollfus; Stéphane Blanche; Florence Buseyne
Journal:  Open Forum Infect Dis       Date:  2016-12-07       Impact factor: 3.835

9.  Lymphocyte homeostasis is maintained in perinatally HIV-infected patients after three decades of life.

Authors:  S Paghera; E Quiros-Roldan; A Sottini; M Properzi; F Castelli; L Imberti
Journal:  Immun Ageing       Date:  2019-10-13       Impact factor: 6.400

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.